Imperial College London

Dr Kirsty Le Doare

Faculty of MedicineDepartment of Medicine

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

k.mehring-le-doare

 
 
//

Location

 

Medical SchoolSt Mary's Campus

//

Summary

 

Summary

I am a Senior Clinical Lecturer and Honorary Paediatric Infectious Diseases Consultant at the Centre for International Child Health at Imperial. My main research interests are age-related immune responses to infectious diseases, in particular to Group B-streptococcus(GBS) in neonates. I am interested in improving our knowledge of how maternal antibody in blood and breast milk is passed to babies and how this protects them from colonisation and disease and how we might improve this with vaccination. I am funded by the the Thrasher Foundation and the Bill and Melinda Gates Foundation.

Membership:

Royal College of Paediatrics and Child Health (RCPCH), Academic Paediatrics Association (APA), British Paediatric Allergy Infection and Immunity Group (BPAIIG), Children's HIV Association (CHIVA) and International Child Health Group.  

 

Publications

Journals

Jones CE, Calvert A, Le Doare K, 2018, Vaccination in Pregnancy—Recent Developments, The Pediatric Infectious Disease Journal, Vol:37, ISSN:0891-3668, Pages:191-193

Idoko OT, Mboizi RB, Okoye M, et al., 2017, Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial, Vaccine, Vol:35, ISSN:0264-410X, Pages:3256-3263

Le Doare K, Faal A, Jaiteh M, et al., 2017, Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort, Vaccine, Vol:35, ISSN:0264-410X, Pages:2970-2978

Le Doare K, Bellis K, Faal A, et al., 2017, SIgA, TGF-beta 1, IL-10, and TNF alpha in Colostrum Are Associated with Infant Group B Streptococcus Colonization, Frontiers in Immunology, Vol:8, ISSN:1664-3224

Kobayashi M, Vekemans J, Baker CJ, et al., 2016, Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries., F1000res, Vol:5, ISSN:2046-1402

More Publications